Post

Servier’s Phase III INDIGO trial of vorasidenib meets endpoints

Servier has reported that the Phase III INDIGO trial of vorasidenib in patients with recurrent or residual grade 2 isocitrate …

AstraZeneca reports positive results from ADAURA Phase III trial

AstraZeneca has reported positive results from the ADAURA Phase III trial of Tagrisso (osimertinib) in the adjuvant treatment of patients …

Vivavision’s Phase IIa study of ophthalmic solution meets primary endpoints

Vivavision Biotech has reported that its Phase IIa first in human study of VVN539 Ophthalmic Solution in the US has met …

Chimeric launches Phase IB trial of glioblastoma multiforme therapy

Chimeric Therapeutics has launched a new Phase IB clinical trial of CHM 1101 (CLXT CAR T) cell therapy to treat …

Elicio reports positive interim clinical data of cancer immunotherapy study

Elicio Therapeutics has reported positive interim clinical data from its ongoing Phase I AMPLIFY-201 study evaluating its cancer immunotherapy, ELI-002, …